Global EditionASIA 中文雙語Fran?ais
Africa

Interest in TCM growing globally

By Shan Juan | China Daily | Updated: 2013-03-29 10:24
Share
Share - WeChat

 

An increasing number of foreigners and foreign pharmaceutical companies are beginning to show a strong interest in traditional Chinese medicine. Provided to China Daily

Chinese mainland accounts for 2% of herbal medicine sales worldwide

While some Chinese experts propose abolishing traditional Chinese medicine, foreign pharmaceutical institutions and industries are pursuing them.

More than 100 countries and regions around the world have set up TCM institutions, with the United States, Europe, Japan and South Korea investing heavily in research and medication development, industry analyses show.

The UK-based pharmaceutical giant GlaxoSmithKline announced its first TCM medication research and development program, which targets not just the Chinese market, but the global one as well.

"TCM is a well-established medical science based on thousands of years of clinical practices. It shows great promise treating complicated conditions that the single-target Western medicine has failed to handle," says Zang Jingwu, senior vice-president and head of GlaxoSmithKline's R&D in China.

"Our priority is to transform TCM from an experience-based practice to evidence-based medicines through innovation and differentiation," he says.

Currently, a 10-person team in Shanghai is in charge of the program, with a medication candidate for skin disease in the works.

Zang, a US-trained neurologist, says TCM is more of a multi-target therapeutical approach, which might work to treat complex conditions.

He said an example of this is ginkgo biloba leaf extract, approved in Germany, which, according to China's pharmacopeia, is TCM in essence. Globally, ginkgo biloba leaf extract is widely used to treat dizziness and ringing in the ears.

Industry insiders call such products "exotic TCM". In ancient TCM works, ginkgo is known for restoring consciousness.

"That is similar to our approach in TCM R&D," he says. He referred to skin diseases for which medications can demonstrate more evidence of effectiveness as a top candidate for TCM. Other areas of research that also show great promise include stomach and intestinal diseases and supplementary treatments for cancer, he adds.

However, given that the culture and ideology of TCM is different from that of Western medicine, great innovation is required to integrate the two sciences, he says.

"In fact, many in Western medicine circles have recognized the importance of TCM, but the problem is how to prove and develop that," says Huang Jianyin, deputy secretary-general of the World Federation of Chinese Medicine Societies.

TCM is developed through empirical testing and refinement of herbal mixtures and relies on clinical experience, and many in the West don't trust that, he said. TCM, particularly herbal products, are largely available in the US and Europe, but questions like how to prove their effectiveness in the context of Western medicine and how to best use them remain unanswered, Zang adds.

Zhang Lingping, director of the international cooperation department of the Beijing University of Chinese Medicine, welcomed the emerging trend.

"Their increasing interest shows Western medicine circles have begun to learn about the time-honored medical science, which originated in China," she says. Zhang says traditionally, Western medicines have been highly targeted and such a method doesn't seem to work well for complex diseases.

"They are beginning to look closely at TCM, which highlights a natural and comprehensive manner in healing," she says.

The university also had partnerships with foreign academic institutions in TCM research focusing on cancer and cardio-cerebrovascular diseases.

A better approach for TCM development is to enhance its dosage and stability, she says.

"It's more feasible and practical for them to improve the techniques during the TCM production, which the multinational pharmaceutical giants are better at," she says.

But that might also pose a challenge for domestic TCM industries, she acknowledges.

Of the global herbal medicine sales volume, the Chinese mainland accounted for only 2 percent, industry analyses show. Japan has the lion's share of the market at 90 percent.

Mao Zedong once expected TCM and Chinese cuisine would be China's two major contributions to the world, Huang says. "He wouldn't have imagined the tough situation today."

shanjuan@chinadaily.com.cn

(China Daily 03/29/2013 page16)

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚洲爆乳无码专区www| 国产国产精品人在线观看| 中文字幕一区二区三区日韩精品| 欧美日韩国产在线人成| 吃奶呻吟打开双腿做受在线视频 | 99久久精品免费精品国产| 日本二区在线观看| 亚洲人成电影院| 狠狠色噜噜狠狠狠888米奇视频 | 欧美乱强伦xxxxx高潮| 免费在线观看黄色毛片| 试看120秒做受小视频免费| 国产精品成人一区二区三区| 人妻少妇无码精品视频区 | 小小的日本电影在线观看免费版| 久久精品日韩Av无码| 欧美理论片在线观看一区二区| 北岛玲在线一区二区| 青青青免费网站在线观看| 国产精品你懂得| 99精品国产99久久久久久97| 成人毛片18女人毛片免费视频未 | 国产青榴视频在线观看网站| 一本精品中文字幕在线| 日本xxxx按摩强| 九九精品视频在线播放8| 欧美最猛黑人xxxx黑人猛交98| 免费无码国产V片在线观看| 色哟哟视频在线观看网站| 国产成人性色视频| 永久在线观看www免费视频| 大狠狠大臿蕉香蕉大视频| 一本色道久久88加勒比—综合| 日本a级作爱片金瓶双艳| 乱人伦视频中文字幕| 欧美性猛交xxxx乱大交中文| 亚洲色无码国产精品网站可下载 | 国产精品久久久久久麻豆一区 | 日韩内射美女片在线观看网站| 亚洲国产欧美在线人成北岛玲| 法国女人与动zozoz0z0|